COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study.
Mario J Valladares-GarridoSandra Zeña-ÑañezC Ichiro PeraltaJacqueline B Puicón-SuárezCristian Díaz-VélezVirgilio E Failoc-RojasPublished in: Vaccines (2022)
COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28-0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- randomized controlled trial
- healthcare
- systematic review
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- emergency department
- public health
- electronic health record
- peritoneal dialysis
- magnetic resonance
- health information
- cardiovascular events
- cardiovascular disease
- big data
- social media
- room temperature
- artificial intelligence